Moxibustion for Mild and Moderate Ulcerative Colitis

The Mechanism of Moxibustion in Treating Ulcerative Colitis Based on Metabonomics

The purpose of this study is to determine whether moxibustion is effective to mild and moderate ulcerative colitis and the effect of moxibustion on metabolism.

Inclusion Criteria:

• Meet the diagnosis of UC
• Mayo ≤10
• Patients should have never received any pharmacological therapy or if they are receiving aminosalicylates and/or prednisolone (the dosage has been taken at least 4 weeks, and should be kept the same as before throughout the trial)
• Patients should have never received antibiotic, biologicals, probiotics, acetaminophen, acetamide and contraceptive.
• A written informed consent

Exclusion Criteria:

• Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases
• Pregnancy or lactation